Drug profile · INN
benzquinamide hydrochloride
EMETE-CON
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
benzquinamide hydrochloride (EMETE-CON) is an FDA-listed pharmaceutical active ingredient. Route of administration: rectal. Current US regulatory status: approved.
Key facts
INN benzquinamide hydrochloride
Brand EMETE-CON
Route RECTAL
Formulation SUPPOSITORY
Frequently asked questions
What is benzquinamide hydrochloride?
benzquinamide hydrochloride (EMETE-CON) is an FDA-listed pharmaceutical active ingredient. Route of administration: rectal. Current US regulatory status: approved.
What is the brand name for benzquinamide hydrochloride?
EMETE-CON is a marketed brand name for benzquinamide hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of benzquinamide hydrochloride?
benzquinamide hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.